000 01498 a2200409 4500
005 20250513220351.0
264 0 _c20010111
008 200101s 0 0 eng d
022 _a0268-3369
024 7 _a10.1038/sj.bmt.1702485
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFrere, P
245 0 0 _aHyperammonemia after high-dose chemotherapy and stem cell transplantation.
_h[electronic resource]
260 _bBone marrow transplantation
_cAug 2000
300 _a343-5 p.
_bdigital
500 _aPublication Type: Case Reports; Journal Article
650 0 4 _aAntineoplastic Combined Chemotherapy Protocols
_xadministration & dosage
650 0 4 _aCyclophosphamide
_xadministration & dosage
650 0 4 _aDexamethasone
_xadministration & dosage
650 0 4 _aDoxorubicin
_xadministration & dosage
650 0 4 _aFemale
650 0 4 _aHematopoietic Stem Cell Transplantation
_xadverse effects
650 0 4 _aHumans
650 0 4 _aHyperammonemia
_xetiology
650 0 4 _aMelphalan
_xadministration & dosage
650 0 4 _aMiddle Aged
650 0 4 _aMultiple Myeloma
_xblood
650 0 4 _aPrednisolone
_xadministration & dosage
650 0 4 _aVincristine
_xadministration & dosage
700 1 _aCanivet, J L
700 1 _aGennigens, C
700 1 _aRebeix, J P
700 1 _aFillet, G
700 1 _aBeguin, Y
773 0 _tBone marrow transplantation
_gvol. 26
_gno. 3
_gp. 343-5
856 4 0 _uhttps://doi.org/10.1038/sj.bmt.1702485
_zAvailable from publisher's website
999 _c10915026
_d10915026